广东药学院学报
廣東藥學院學報
엄동약학원학보
ACADEMIC JOURNAL OF GUANGDONG COLLEGE OF PHARMACY
2014年
4期
501-504
,共4页
蓝玉宏%邵汛帆%白力%江晓聪%谢福川
藍玉宏%邵汛帆%白力%江曉聰%謝福川
람옥굉%소신범%백력%강효총%사복천
乏氧诱导因子-1α%鼻咽癌细胞%表达%预后
乏氧誘導因子-1α%鼻嚥癌細胞%錶達%預後
핍양유도인자-1α%비인암세포%표체%예후
HIF-1 alpha%nasopharyngeal cancer cell%expression%prognosis
目的:观察乏氧诱导因子-1α( HIF-1α)在鼻咽癌细胞中的表达情况及其与预后的关系。方法通过治疗前检测200例鼻咽癌患者HIF-1α的表达情况,并分析阳性、阴性表达组治疗疗效来研究其与鼻咽癌预后的关系。结果200例鼻咽癌患者中 HIF-1α表达阳性者151例(75.5%),表达阴性者49例(24.5%)。Ⅰ、Ⅱ期表达阴性、阳性患者的疗效比较差异无统计学意义。Ⅲ~Ⅳa期患者表达阳性者的完全缓解率(85.9%、80.4%)低于表达阴性者(91.7%、84.6%),差异有统计学意义( P=0.032, P=0.041),2年局控率表达阳性者(74.6%、69.6%)低于表达阴性者(87.5%、76.9%),差异有统计学意义(P=0.021、P=0.035),2年生存率表达阳性者(84.5%、76.1%)低于表达阴性患者(95.8%、84.6%),差异有统计学意义( P=0.037、P=0.042)。结论大部分鼻咽癌患者呈现HIF-1α表达阳性,对于Ⅲ~Ⅳa期患者HIF-1α表达阳性与不良预后相关。
目的:觀察乏氧誘導因子-1α( HIF-1α)在鼻嚥癌細胞中的錶達情況及其與預後的關繫。方法通過治療前檢測200例鼻嚥癌患者HIF-1α的錶達情況,併分析暘性、陰性錶達組治療療效來研究其與鼻嚥癌預後的關繫。結果200例鼻嚥癌患者中 HIF-1α錶達暘性者151例(75.5%),錶達陰性者49例(24.5%)。Ⅰ、Ⅱ期錶達陰性、暘性患者的療效比較差異無統計學意義。Ⅲ~Ⅳa期患者錶達暘性者的完全緩解率(85.9%、80.4%)低于錶達陰性者(91.7%、84.6%),差異有統計學意義( P=0.032, P=0.041),2年跼控率錶達暘性者(74.6%、69.6%)低于錶達陰性者(87.5%、76.9%),差異有統計學意義(P=0.021、P=0.035),2年生存率錶達暘性者(84.5%、76.1%)低于錶達陰性患者(95.8%、84.6%),差異有統計學意義( P=0.037、P=0.042)。結論大部分鼻嚥癌患者呈現HIF-1α錶達暘性,對于Ⅲ~Ⅳa期患者HIF-1α錶達暘性與不良預後相關。
목적:관찰핍양유도인자-1α( HIF-1α)재비인암세포중적표체정황급기여예후적관계。방법통과치료전검측200례비인암환자HIF-1α적표체정황,병분석양성、음성표체조치료료효래연구기여비인암예후적관계。결과200례비인암환자중 HIF-1α표체양성자151례(75.5%),표체음성자49례(24.5%)。Ⅰ、Ⅱ기표체음성、양성환자적료효비교차이무통계학의의。Ⅲ~Ⅳa기환자표체양성자적완전완해솔(85.9%、80.4%)저우표체음성자(91.7%、84.6%),차이유통계학의의( P=0.032, P=0.041),2년국공솔표체양성자(74.6%、69.6%)저우표체음성자(87.5%、76.9%),차이유통계학의의(P=0.021、P=0.035),2년생존솔표체양성자(84.5%、76.1%)저우표체음성환자(95.8%、84.6%),차이유통계학의의( P=0.037、P=0.042)。결론대부분비인암환자정현HIF-1α표체양성,대우Ⅲ~Ⅳa기환자HIF-1α표체양성여불량예후상관。
Objective To evaluate the expression of hypoxia-inducible factor-1 alpha ( HIF-1α) in nasopharyngeal cancer cells and its relationship with disease prognosis. Methods 200 patients with nasopharyngeal carcinoma( NPC) in our hospital were collected. The expression of HIF-1αwas detected by immunohistochemistry. The relationship of the HIF-1α expression with disease prognosis was analyzed. Results The number of HIF-1α positive expression was 151 cases ( 75. 5%) , and the number of HIF-1αnegative expression was 49 cases ( 24. 5%) . For stage Ⅰ and Ⅱ patients, the curative effects was no difference between HIF-1α positive and negative expression groups. For stage Ⅲ and Ⅳa patients, the complete tumor regression rate in HIF-1α positive and negative expression groups after treatment was (85. 9%and 80.4%) and(91.7%and 84.6%),respectively,and the difference was statistically significant. The local control rate after 2 years of treatment in HIF-1α positive group ( 74. 6% and 69. 6%) was significantly lower than HIF-1α negative expression group(87.5% and 76.9%). The survival rate after 2 years of treatment in HIF-1α positive expression group ( 84. 5% and 76. 1%) was significantly lower than HIF-1αnegative expression group(95.8%and 84.6%). Conclusion HIF-1αis positively expressed in most of NPC,which is correlated with poor prognosis of stage Ⅲ and Ⅳa patients.